Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trials
Open Access
- 5 April 2024
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 71, 102581
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Recognizing and Monitoring Adverse Events of Second-Generation Antipsychotics in Children and AdolescentsChild and Adolescent Psychiatric Clinics of North America, 2006
- Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES IIISchizophrenia Research, 2005
- Lithium induces phosphoglucomutase activity in various tissues of rats and in bipolar patientsInternational Journal of Neuropsychopharmacology, 2005
- Prise de poids pharmaco-induite par les psychotropes et sa prise en charge : revue des données de la littératureL'Encéphale, 2005
- Bipolar disorder: disease burden.2005
- Volume reduction of the amygdala in patients with schizophrenia: a magnetic resonance imaging studyPsychiatry Research: Neuroimaging, 2004
- Weight gain and glucose and lipid metabolism disturbances during antipsychotic medicationEuropean Archives of Psychiatry and Clinical Neuroscience, 2002
- Reduction of Prefrontal Cortex Glucose Metabolism Common to Three Types of DepressionArchives of General Psychiatry, 1989
- Lithium treatment and glucose tolerance in manic-melancholic patientsActa Psychiatrica Scandinavica, 1979
- Plasma Prolactin during Lithium TreatmentNeuropsychobiology, 1977